Identifying predictive biomarkers for long term response on immunotherapy in non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Decoster, L. [1 ]
Nazari, S. [2 ]
De Ridder, K. [3 ]
Giron, P. [4 ]
Vekens, K. [5 ]
Goyvaerts, C. [6 ]
机构：
[1] UZ Brussel Univ Ziekenhuis Brussel, Dept Med Oncol, Jette, Belgium
[2] Vrije Univ Brussel, Med Oncol, Fac Med & Pharm, Brussels, Belgium
[3] Vrije Univ Brussel, Dept Biomed Sci, Lab Mol & Cellular Therapy, Fac Med & Pharm, Brussels, Belgium
[4] UZ Brussel Univ Ziekenhuis Brussel, Dept Clin Genet, Jette, Belgium
[5] UZ Brussel Univ Ziekenhuis Brussel, Div Resp, Jette, Belgium
[6] Vrije Univ Brussel, Lab Mol & Cellular Therapy, Fac Med & Pharm, Brussels, Belgium
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.07.1221
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1096P
引用
收藏
页码：S1052 / S1052
页数：1
相关论文
共 50 条
  • [21] Evaluation of combined biomarkers for tumor response to immunotherapy (I/O) in patients with advanced non-small cell lung cancer (NSCLC)
    Ramdani, H.
    Falk, M.
    Schatz, S.
    Heukamp, L. C.
    Tiemann, M.
    Schuuring, E.
    Groen, H.
    Griesinger, F.
    PNEUMOLOGIE, 2020, 74 : S127 - S128
  • [22] Analysis of correlations between driver mutations and biomarkers with response to immunotherapy in patients with metastatic non-small cell lung cancer (NSCLC).
    Yio, Jiang
    Wolf, Brian
    Yang, Amber
    Bayewitz, Ashrei Y.
    Xu, Yiqing
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [23] Evaluation of combined biomarkers for tumor response to immunotherapy (I/O) in patients with advanced non-small cell lung cancer (NSCLC)
    Ramdani, H.
    Falk, M.
    Schatz, S.
    Tiemann, M.
    Heukamp, L. C.
    Schuuring, E.
    Groen, H. J.
    Griesinger, F.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 77 - 77
  • [24] Evaluation of combined biomarkers for tumor response to immunotherapy (I/O) in patients with advanced non-small cell lung cancer (NSCLC).
    Ramdani, Hayat Oum El Kheir
    Falk, Markus
    Schatz, Stefanie
    Tiemann, Markus
    Heukamp, Lukas
    Schuuring, Ed
    Groen, Harry J. M.
    Griesinger, Frank
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [25] Evaluation of Combined Biomarkers for Tumor Response to Immunotherapy (I/O) in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
    Ramdani, H.
    Falk, M.
    Schatz, S.
    Tiemann, M.
    Heukamp, L.
    Schuuring, E.
    Groen, H.
    Griesinger, F.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S732 - S733
  • [26] Soluble Biomarkers with Prognostic and Predictive Value in Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy
    Honrubia-Peris, Beatriz
    Garde-Noguera, Javier
    Garcia-Sanchez, Jose
    Piera-Molons, Nuria
    Llombart-Cussac, Antonio
    Fernandez-Murga, Maria Leonor
    CANCERS, 2021, 13 (17)
  • [27] The Combination of Radiotherapy With Immunotherapy and Potential Predictive Biomarkers for Treatment of Non-Small Cell Lung Cancer Patients
    Meng, Lu
    Xu, Jianfang
    Ye, Ying
    Wang, Yingying
    Luo, Shilan
    Gong, Xiaomei
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [28] Immunotherapy causing pneumonitis in a patient with non-small cell lung cancer (NSCLC)
    Li, Rui
    Lee, Gina
    El-Sherief, Ahmed
    BMJ CASE REPORTS, 2019, 12 (03)
  • [29] Implementation of immunotherapy in the treatment of advanced non-small cell lung cancer (NSCLC)
    Tsiara, Anna
    Liontos, Michalis
    Kaparelou, Maria
    Zakopoulou, Roubini
    Bamias, Aristotelis
    Dimopoulos, Meletios-Athanasios
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (08)
  • [30] Immunotherapy and Vaccination in Surgically Resectable Non-Small Cell Lung Cancer (NSCLC)
    Chiu, Li-Chung
    Lin, Shu-Min
    Lo, Yu-Lun
    Kuo, Scott Chih-Hsi
    Yang, Cheng-Ta
    Hsu, Ping-Chih
    VACCINES, 2021, 9 (07)
12345